Millennium Management’s Rosetta Genomics Ltd. ROSG Stock Holding History

Millennium Management’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,058	Closed	-$43K	–	3936
2015 Q2	$43K	Sell	1,058 -1,943	-65%	-$83.1K	﹤0.01%	3226
2015 Q1	$111K	Buy	+3,001	New	+$114K	﹤0.01%	3391
2014 Q2	–	Sell	-2,070	Closed	-$124K	–	4155
2014 Q1	$124K	Buy	+2,070	New	+$107K	﹤0.01%	3275
2013 Q4	–	Sell	-1,175	Closed	-$45K	–	3990
2013 Q3	$45K	Sell	1,175 -83	-7%	-$3.37K	﹤0.01%	3230
2013 Q2	$51K	Buy	+1,258	New	+$55.9K	﹤0.01%	2911

Other funds holding ROSG

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ICAS

Investors Capital Advisory Services Lynnfield, Massachusetts $521M AUM 1.51% 1-Year Est. Return

RCM

Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return

Gerstein Fisher New York $811M AUM 13.96% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management's ROSG Position: Q3 2015 in Review

Millennium Management sold out of Rosetta Genomics Ltd. (ROSG) in Q3 2015, closing a stake of 1,058 shares — an estimated $43K sold.

Millennium Management first reported a position in ROSG in Q2 2013 and held it in 5 quarters. The position peaked at $124K in Q1 2014. 11 funds tracked by Wall St. Rank hold ROSG as of Q3 2015.

Millennium Management reported no remaining Rosetta Genomics Ltd. position as of Q3 2015 after selling out during the quarter.
Millennium Management sold 1,058 Rosetta Genomics Ltd. shares in Q3 2015, an estimated $43K.
Millennium Management first reported a position in Rosetta Genomics Ltd. in Q2 2013 and held it in 5 quarters.
Millennium Management's Rosetta Genomics Ltd. position peaked at $124K in Q1 2014.
11 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q3 2015.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.